Trinchet J C, Hartmann D J, Pateron D, Munz-Gotheil C, Callard P, Ville G, Beaugrand M
Services d'Hépato-gastroentérologie et d'Anatomopathologie, Hôpital Jean Verdier, France.
Alcohol Clin Exp Res. 1992 Apr;16(2):342-6. doi: 10.1111/j.1530-0277.1992.tb01388.x.
This study compared, in patients with alcoholic liver disease, the serum concentration of N-terminal peptide of type III procollagen and of a novel serum marker, type I collagen, with liver histological data and assessed the role of these markers in the diagnosis and follow-up of liver changes. Ninety-six patients (mean age 51 years, 61 men and 35 women) were included. All had alcoholic liver disease diagnosed on usual clinical, biochemical, and histological criteria. Two histological scores, one for alcoholic hepatitis and one for fibrosis, were established. Serum N-terminal peptide of type III procollagen and type I collagen were assayed by liquid phase radioimmunoassay. Significant correlations between serum type I collagen and score of fibrosis (r = 0.34, p less than 0.001) and between serum N-terminal peptide of type III procollagen and score of alcoholic hepatitis (r = 0.60, p less than 0.0001) were noted. There was no significant correlation between serum aminotransferases and the score of alcoholic hepatitis. In 25 patients with alcoholic hepatitis reassessed between 3 and 6 months, serum N-terminal peptide of type III procollagen significantly decreased (p less than 0.05) as did the score of alcoholic hepatitis, but serum type I collagen and the score of fibrosis were not modified. These serum markers of collagen metabolism could be useful for the assessment and follow-up in patients with alcoholic liver disease.
本研究在酒精性肝病患者中,比较了血清III型前胶原N端肽和一种新型血清标志物I型胶原的浓度与肝脏组织学数据,并评估了这些标志物在肝脏变化诊断和随访中的作用。纳入了96例患者(平均年龄51岁,61例男性和35例女性)。所有患者均根据常规临床、生化和组织学标准诊断为酒精性肝病。建立了两种组织学评分,一种用于酒精性肝炎,一种用于纤维化。采用液相放射免疫分析法检测血清III型前胶原N端肽和I型胶原。观察到血清I型胶原与纤维化评分之间存在显著相关性(r = 0.34,p < 0.001),血清III型前胶原N端肽与酒精性肝炎评分之间存在显著相关性(r = 0.60,p < 0.0001)。血清转氨酶与酒精性肝炎评分之间无显著相关性。在25例于3至6个月期间重新评估的酒精性肝炎患者中,血清III型前胶原N端肽显著下降(p < 0.05),酒精性肝炎评分也显著下降,但血清I型胶原和纤维化评分未改变。这些胶原代谢的血清标志物可能有助于酒精性肝病患者的评估和随访。